BlissBio is a clinical-stage biotech company focused on the discovery, development, and commercialization of oncology biological therapeutics, with multiple innovative tumor-targeting ADCs in Phase I and II clinical trials
BlissBio is a clinical-stage biotech company focused on the discovery, development, and commercialization of oncology biological therapeutics, with multiple innovative tumor-targeting ADCs in Phase I and II clinical trials.